Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systemic antibiotics in implant surgery with guided bone regeneration and sinus floor elevation
2024-511366-36-00Phase 4Authorised
- Sponsor
- Medical University of Graz
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in surgical site infection (SSI) comparing Amoxicillin (Moxilen) with Placebo (Amylium Maydis) (2 arms). Primary endpoint: Patient Reported Outcome Measures (PROMs) on wound and sinus discomfort. Planned start Dec 2022; status: authorised.
02
Drugs
amoxicillin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on 2024-511366-36-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511366-36-00.